AI処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

臨床ガイドラインに基づき処方箋を自動審査し、相互作用や用量リスクを特定し、標準化された報告書を生成します。

プロンプト内容

コピー

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, renal/hepatic function, and allergy history. Second, check for drug interactions, contraindications, or off-label usage risks based on current clinical guidelines. Finally, if potential risks are identified, clearly specify the risk type and provide specific adjustment suggestions or alternative solutions, ensuring the output is concise, professional, and adheres to medical safety standards.

コピー

ベテランの臨床薬剤師として、提供された患者の処方箋のコンプライアンスを審査してください。まず、薬剤名、用量、投与経路、頻度を抽出し、患者の年齢、肝腎機能、アレルギー歴と照合します。次に、最新の臨床ガイドラインに基づき、薬物相互作用、禁忌症、または適応外使用のリスクを確認します。最後に、潜在的なリスクが特定された場合は、リスクの種類を明確にし、具体的な調整提案または代替案を提供し、出力が簡潔で専門的かつ医療安全基準に準拠していることを確保してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all drug names with dosages. Second, cross-reference these details against the latest clinical guidelines and package inserts to check for contraindications, drug-drug interactions, or dosage errors. Finally, if any safety risks are identified, clearly specify the risk and provide evidence-based adjustment suggestions or alternative therapies to support clinical decision-making.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze whether this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, particularly regarding the risk of using non-steroidal anti-inflammatory drugs in patients with renal insufficiency, and provide specific adjustment suggestions or alternative solutions to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following simulated prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and Ibuprofen 400mg tid (for osteoarthritis pain). Analyze if there are drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of NSAID use in patients with renal impairment, and provide specific adjustment suggestions or alternative plans to ensure medication safety and compliance with clinical guidelines.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.